Skip To Main Content
Olivia Rafferty on Muck Rack

Olivia Rafferty

Verified
(She/Her)
Sardinia
As seen in: Intellectual Asset Management (IAM), Al-Araby Al-Jadeed, Global Data Review, Lexology, World Trademark Review (WTR), Thred, Global Competition Review, The Vegan Review
Covers:  Climate change, Gen-Z issues, human rights, competition law, antitrust, business, intellectual property, artificial intelligence.
Reporter ip fray, ai fray 🖋@IAM_Alerts @gcr_alerts @ThredMag @The_NewArab. Irish. Vegan. T1D. Retweets ≠ endorsements, views my own!

Get in touch with Olivia

Contact Olivia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

FTC urges Fourth Circuit to reject Amgen plea to shield Roche patent acquisition: deal “threatens to upend” long-settled antitrust framework

|
By Olivia Rafferty Verified
| ipfray.com
Context: In 1998, Immunex Corporation (acquired by Amgen in 2002) launched Enbrel in the U.S. to treat inflammatory diseases like rheumatoid arthritis. Roche, however, had already described etanercept in its own patent applications, so Immunex obtained a non-exclusive license to the relevant patents from Roche.
Open in Who Shared Issue with article?

Canadian Solar, Maxeon settle U.S. patent dispute

|
By Olivia Rafferty Verified
| ipfray.com
Context: Maxeon Solar Technologies, a Singapore-based solar panel manufacturer, sued Canadian Solar in both Japan and the U.S. over the alleged infringement of several of its solar cell module-related patents. In Japan, it filed an action in the Tokyo District Court in September 2020 (over JP6642841 (“Shingled solar cell module”), which ultimately led to a settlement in April 2022.
Open in Who Shared Issue with article?

EWHC hinders Accord’s plans to launch Entresto competing product in Novartis patent dispute

|
By Olivia Rafferty Verified
| ipfray.com
In-depth reporting and analytical commentary on intellectual property disputes and debates. No legal advice. August 14, 2026 Continue reading your article with a Membership Court: Mr. Justice Meade of the High Court of Justice for England & Wales. Accord is being represented by a team at Pinsent Masons, as well as Thomas Hinchliffe KC and Thomas Lunt. Meanwhile, Novartis is being represented by a team at Bristows, as well as Thomas Mitcheson KC, Stuart Baran, and Bethany Halbard.
Open in Who Shared Issue with article?
See all 831 articles